Drug delivery is a term that refers
to the administering of a pharmaceutical ingredient
in humans or animals via oral, nasal, dermal and rectal
routes. One of the major constraints in the existing
drug delivery systems is the dispensing of drug at infected
site. This determines the actual concentration of the
drug available at infected site and hence its efficacy.
The use of a proper vehicle which can transfer the active
ingredient at the right concentration to the receptor
site is a major challenge in designing the novel drug
delivery system.
Polymers are used extensively as
drug delivery vehicles since they are relatively inert.
However these polymers being polydisperse in nature
are not most ideal candidates for a drug delivery system.
We at Bioplus have developed a novel monodisperse polymeric
drug delivery vehicle which can perform as both as the
targeted as well as sustained release drug delivery
systems. Our system ensures increased bioavailability
of the drug at the required site.
The information contained in this publication is based on our own research and development work and is to the best of our knowledge reliable. Users should, however, conduct their own tests to determine the suitability of our products for their own specific purposes and the legal status for their intended use of the product. Statements contained herein should not be considered as a warranty of any kind, expressed or implied, and no liability is accepted for the infringement of any patents.
